These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

730 related items for PubMed ID: 27851970

  • 1. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.
    Mandoli A, Singh AA, Prange KHM, Tijchon E, Oerlemans M, Dirks R, Ter Huurne M, Wierenga ATJ, Janssen-Megens EM, Berentsen K, Sharifi N, Kim B, Matarese F, Nguyen LN, Hubner NC, Rao NA, van den Akker E, Altucci L, Vellenga E, Stunnenberg HG, Martens JHA.
    Cell Rep; 2016 Nov 15; 17(8):2087-2100. PubMed ID: 27851970
    [Abstract] [Full Text] [Related]

  • 2. ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia.
    Martens JH, Mandoli A, Simmer F, Wierenga BJ, Saeed S, Singh AA, Altucci L, Vellenga E, Stunnenberg HG.
    Blood; 2012 Nov 08; 120(19):4038-48. PubMed ID: 22983443
    [Abstract] [Full Text] [Related]

  • 3. An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells.
    Zaidi SK, Perez AW, White ES, Lian JB, Stein JL, Stein GS.
    Oncotarget; 2017 Jun 20; 8(25):39994-40005. PubMed ID: 28611288
    [Abstract] [Full Text] [Related]

  • 4. The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes.
    Bakshi R, Zaidi SK, Pande S, Hassan MQ, Young DW, Montecino M, Lian JB, van Wijnen AJ, Stein JL, Stein GS.
    J Cell Sci; 2008 Dec 01; 121(Pt 23):3981-90. PubMed ID: 19001502
    [Abstract] [Full Text] [Related]

  • 5. Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells.
    Trombly DJ, Whitfield TW, Padmanabhan S, Gordon JA, Lian JB, van Wijnen AJ, Zaidi SK, Stein JL, Stein GS.
    BMC Genomics; 2015 Apr 17; 16(1):309. PubMed ID: 25928846
    [Abstract] [Full Text] [Related]

  • 6. YTHDF2 is a potential target of AML1/ETO-HIF1α loop-mediated cell proliferation in t(8;21) AML.
    Chen Z, Shao YL, Wang LL, Lin J, Zhang JB, Ding Y, Gao BB, Liu DH, Gao XN.
    Oncogene; 2021 Jun 17; 40(22):3786-3798. PubMed ID: 33958724
    [Abstract] [Full Text] [Related]

  • 7. ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation.
    Liu J, Lu W, Liu S, Wang Y, Li S, Xu Y, Xing H, Tang K, Tian Z, Rao Q, Wang M, Wang J.
    Leuk Res; 2018 May 17; 68():15-21. PubMed ID: 29518627
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia.
    Dunne J, Gascoyne DM, Lister TA, Brady HJ, Heidenreich O, Young BD.
    Cancer Res; 2010 May 15; 70(10):3985-95. PubMed ID: 20460523
    [Abstract] [Full Text] [Related]

  • 10. Histone deacetylase 3 preferentially binds and collaborates with the transcription factor RUNX1 to repress AML1-ETO-dependent transcription in t(8;21) AML.
    Guo C, Li J, Steinauer N, Wong M, Wu B, Dickson A, Kalkum M, Zhang J.
    J Biol Chem; 2020 Mar 27; 295(13):4212-4223. PubMed ID: 32071087
    [Abstract] [Full Text] [Related]

  • 11. Epigenetic silencing of miR564 contributes to the leukemogenesis of t(8;21) acute myeloid leukemia.
    Yang E, Guan W, Gong D, Gao X, Han C, Zhang J, Wang H, Wang M, Li Y, Yu L.
    Clin Sci (Lond); 2020 Dec 11; 134(23):3079-3091. PubMed ID: 33201243
    [Abstract] [Full Text] [Related]

  • 12. Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival.
    Dayyani F, Wang J, Yeh JR, Ahn EY, Tobey E, Zhang DE, Bernstein ID, Peterson RT, Sweetser DA.
    Blood; 2008 Apr 15; 111(8):4338-47. PubMed ID: 18258796
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Definition of a small core transcriptional circuit regulated by AML1-ETO.
    Stengel KR, Ellis JD, Spielman CL, Bomber ML, Hiebert SW.
    Mol Cell; 2021 Feb 04; 81(3):530-545.e5. PubMed ID: 33382982
    [Abstract] [Full Text] [Related]

  • 15. RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.
    Ptasinska A, Pickin A, Assi SA, Chin PS, Ames L, Avellino R, Gröschel S, Delwel R, Cockerill PN, Osborne CS, Bonifer C.
    Cell Rep; 2019 Sep 17; 28(12):3022-3031.e7. PubMed ID: 31533028
    [Abstract] [Full Text] [Related]

  • 16. AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia.
    Fu L, Huang W, Jing Y, Jiang M, Zhao Y, Shi J, Huang S, Xue X, Zhang Q, Tang J, Dou L, Wang L, Nervi C, Li Y, Yu L.
    FEBS J; 2014 Feb 17; 281(4):1123-31. PubMed ID: 24314118
    [Abstract] [Full Text] [Related]

  • 17. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.
    Vangala RK, Heiss-Neumann MS, Rangatia JS, Singh SM, Schoch C, Tenen DG, Hiddemann W, Behre G.
    Blood; 2003 Jan 01; 101(1):270-7. PubMed ID: 12393465
    [Abstract] [Full Text] [Related]

  • 18. Genome-wide studies identify a novel interplay between AML1 and AML1/ETO in t(8;21) acute myeloid leukemia.
    Li Y, Wang H, Wang X, Jin W, Tan Y, Fang H, Chen S, Chen Z, Wang K.
    Blood; 2016 Jan 14; 127(2):233-42. PubMed ID: 26546158
    [Abstract] [Full Text] [Related]

  • 19. Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO.
    Da Silva N, Meyer-Monard S, Menot ML, Parrado A, Lebel A, Balitrand N, Fenaux P, Micléa JM, Rousselot P, Degos L, Dombret H, Chomienne C.
    Hematol J; 2000 Jan 14; 1(5):316-28. PubMed ID: 11920209
    [Abstract] [Full Text] [Related]

  • 20. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations.
    Yuan Y, Zhou L, Miyamoto T, Iwasaki H, Harakawa N, Hetherington CJ, Burel SA, Lagasse E, Weissman IL, Akashi K, Zhang DE.
    Proc Natl Acad Sci U S A; 2001 Aug 28; 98(18):10398-403. PubMed ID: 11526243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.